Dixie Brands Aceso Calm Cannabis Spray Approved in New Zealand for Tourette's Syndrome

Aceso Calm

Dixie Brands launched a line of health and wellness products in late 2015 under the brand name Aceso.  The herbal supplements contain cannabinoids derived from industrial hemp. New Zealand has approved this supplement for use by a single individual, as Associate Health Minister Peter Dunne received an application on April 1st from a patient with Tourette’s Syndrome and approved it today.  He had previously approved an Elixinol product last year.

Dunne approved the spray because it has fewer side effects than Sativex, which is sold by GW Pharma (NASDAQ: GWPH), and because it met 7 out of 8 criteria. Aceso Calm, according to the company, has 335mg of cannabinoids per 1 oz. bottle (5mg of CBD per spray) and includes terpenes limonene and linalool as well as passionflower extract and CoQ10.

Read Jo Moir’s “Peter Dunne approves cannabis product for Tourette’s Syndrome patient”: http://www.stuff.co.nz/national/health/78546650/peter-dunne-approves-new-cannabis-product-for-patient-with-tourettes-syndrome

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter